Emergent BioSolutions EBS
NYSE EBS
$6.76 +0.21 (+3.21%)
At close: Sep 22, 2026 · 4:00 PM EDT

Emergent BioSolutions (EBS) Total Debt (2010 - 2026)

Emergent BioSolutions (EBS) posted Total Debt of $589.7 million for Q2 2026, little changed on a QoQ basis from $589.7 million in Q1 2026, and down 15.76% year-over-year from $700.0 million in Q2 2025.

Analysis

Emergent BioSolutions (EBS) Total Debt (2010 - 2026) Analysis & Trends

Emergent BioSolutions has reported Total Debt for 17 years, with the latest figure at $589.7 million in Q2 2026.

  • On a quarterly basis, Total Debt fell 15.76% year-over-year to $589.7 million in Q2 2026; TTM through Jun 2026 was $589.7 million, a 15.76% decrease from a year earlier, with the FY2025 full-year figure at $589.7 million, down 15.76% from the prior year.
  • Total Debt was $589.7 million for Q2 2026 at Emergent BioSolutions, roughly flat from $589.7 million in the prior quarter.
  • The five-year high for Total Debt was $2.4 billion in Q4 2022, with the low at $589.7 million in Q4 2025.
  • Average Total Debt over 5 years is $1.1 billion, with a median of $868.5 million recorded in 2022.
  • The sharpest annual moves came in 2023 and 2025: Total Debt jumped 169.98% in 2023, then slumped 48.85% in 2025.
  • Over 5 years, Total Debt stood at $2.4 billion in 2022, then sank by 45.93% to $1.3 billion in 2023, then plunged by 45.4% to $700.0 million in 2024, then decreased by 15.76% to $589.7 million in 2025, then changed by 0.0% to $589.7 million in 2026.
  • The last three Total Debt figures came in at $589.7 million (Q2 2026), $589.7 million (Q1 2026), and $589.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Johnson & Johnson 649.47 Bn 628.71 Bn 17.26 Bn 60.73 Bn
2 AbbVie 467.46 Bn 460.93 Bn 12.70 Bn 70.82 Bn
3 Merck 369.31 Bn 362.22 Bn 12.21 Bn 53.91 Bn
4 Novartis Ag 269.03 Bn 261.74 Bn 11.24 Bn 9.59 Bn
5 Pfizer 158.11 Bn 146.71 Bn 10.94 Bn 63.19 Bn
6 Bristol Myers Squibb 127.96 Bn 116.89 Bn 9.25 Bn 43.89 Bn
7 Sanofi 51.83 Bn 44.86 Bn 10.79 Bn 25.19 Bn
8 BeOne Medicines 41.33 Bn 36.23 Bn 1.53 Bn 1.07 Bn
9 Revolution Medicines 41.30 Bn 41.30 Bn - -
10 Emergent BioSolutions 335.50 Mn 194.60 Mn 137.20 Mn 589.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 589.70 Mn
Mar 31, 2026 589.70 Mn
Dec 31, 2025 589.70 Mn
Sep 30, 2025 693.10 Mn
Jun 30, 2025 700.00 Mn
Mar 31, 2025 700.00 Mn
Dec 31, 2024 700.00 Mn
Sep 30, 2024 701.60 Mn
Jun 30, 2024 1.28 Bn
Mar 31, 2024 1.37 Bn
Dec 31, 2023 1.28 Bn
Sep 30, 2023 1.28 Bn
Jun 30, 2023 1.36 Bn
Mar 31, 2023 2.36 Bn
Dec 31, 2022 2.37 Bn
Sep 30, 2022 1.05 Bn
Jun 30, 2022 864.30 Mn
Mar 31, 2022 872.70 Mn
Dec 31, 2021 881.20 Mn
Sep 30, 2021 889.60 Mn
API Access

Emergent BioSolutions Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=EBS&period=max&api_key=YOUR_API_KEY